针对接受个体创伤后应激障碍治疗的退伍军人家庭成员的简短辅助干预措施的开发与初步测试。
Development and initial testing of a brief adjunctive intervention for family members of veterans in individual PTSD treatment.
作者信息
Thompson-Hollands Johanna, Strage Michele, DeVoe Ellen R, Beidas Rinad S, Sloan Denise M
机构信息
National Center for PTSD, VA Boston Healthcare System.
Boston University School of Medicine.
出版信息
Cogn Behav Pract. 2021 May;28(12):193-209. doi: 10.1016/j.cbpra.2020.06.007.
Family involvement in the treatment of posttraumatic stress disorder (PTSD) among veterans has the potential to improve treatment retention and outcomes. Current protocols that incorporate family members into treatment tend to involve at least 15 sessions, and none are designed to complement Cognitive Processing Therapy (CPT) or Prolonged Exposure (PE), the two most widely used and heavily promoted evidence-based PTSD therapies in the Veterans Affairs (VA) healthcare system. The current paper describes the development and initial feasibility and acceptability of a Brief Family Intervention (the BFI) designed to be delivered as an adjunct to veterans' individual CPT/PE. The BFI focuses on providing psychoeducation about PTSD and treatment, building family member support for treatment, and reducing family symptom accommodation. A detailed review of the treatment structure and activities is provided, and qualitative data from four dyads (veterans and their spouses/significant others) at baseline and post-intervention are presented. Veterans and partners reported positive responses to the program and were enthusiastic about its utility. Larger randomized controlled studies will be needed to determine the protocol's efficacy and effectiveness.
让家庭成员参与退伍军人创伤后应激障碍(PTSD)的治疗,有可能提高治疗的持续性和治疗效果。目前将家庭成员纳入治疗的方案往往至少需要15次治疗,而且没有一个方案是专门为辅助认知加工疗法(CPT)或延长暴露疗法(PE)而设计的,这两种疗法是退伍军人事务部(VA)医疗系统中使用最广泛、推广力度最大的循证PTSD疗法。本文描述了一种简短家庭干预(BFI)的开发过程以及其初步的可行性和可接受性,该干预旨在作为退伍军人个体CPT/PE治疗的辅助手段。BFI的重点是提供有关PTSD及其治疗的心理教育,建立家庭成员对治疗的支持,并减少家庭对症状的迁就。文中提供了对治疗结构和活动的详细回顾,并展示了来自四个二元组(退伍军人及其配偶/重要他人)在基线和干预后的定性数据。退伍军人及其伴侣对该方案给出了积极反馈,并对其效用充满热情。需要开展更大规模的随机对照研究来确定该方案的疗效和有效性。